IL146142A0 - 2-substituted-5'-o-(1-boranotriphosphate adenosine derivatives and pharmaceutical compositions comprising them for treatment of type 2 diabetes - Google Patents
2-substituted-5'-o-(1-boranotriphosphate adenosine derivatives and pharmaceutical compositions comprising them for treatment of type 2 diabetesInfo
- Publication number
- IL146142A0 IL146142A0 IL14614201A IL14614201A IL146142A0 IL 146142 A0 IL146142 A0 IL 146142A0 IL 14614201 A IL14614201 A IL 14614201A IL 14614201 A IL14614201 A IL 14614201A IL 146142 A0 IL146142 A0 IL 146142A0
- Authority
- IL
- Israel
- Prior art keywords
- boranotriphosphate
- diabetes
- substituted
- treatment
- type
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14614201A IL146142A0 (en) | 2001-10-24 | 2001-10-24 | 2-substituted-5'-o-(1-boranotriphosphate adenosine derivatives and pharmaceutical compositions comprising them for treatment of type 2 diabetes |
JP2003537547A JP2005508970A (ja) | 2001-10-24 | 2002-10-23 | 抗糖尿病性の2−置換−5’−o−(1−ボラノトリホスフェート)アデノシン誘導体 |
IL16143302A IL161433A0 (en) | 2001-10-24 | 2002-10-23 | 2-substituted-5'-o-(1-boranotriphosphate) adenosine derivatives and pharmaceutical compositions comprising them for treatment of diabetes |
EP02777766A EP1446132A4 (fr) | 2001-10-24 | 2002-10-23 | Derives antidiabetiques de 5'-o-(1-boranotriphosphate) adenosine-2-substituee |
CA002462250A CA2462250A1 (fr) | 2001-10-24 | 2002-10-23 | Derives antidiabetiques de 5'-o-(1-boranotriphosphate) adenosine-2-substituee |
NZ532171A NZ532171A (en) | 2001-10-24 | 2002-10-23 | Antidiabetic 2-Substituted-5'-O- (1-boranotriphosphate) adenosine derivatives |
CNA028211936A CN1575180A (zh) | 2001-10-24 | 2002-10-23 | 抗糖尿病的2-取代的-5′-o-(1-甲硼烷代三磷酸盐)腺苷衍生物 |
BR0206190-2A BR0206190A (pt) | 2001-10-24 | 2002-10-23 | Derivados antidiabéticos de 2-substituìdos-5'o-(1-boranotrifosfato) adenosina |
US10/493,461 US7319093B2 (en) | 2001-10-24 | 2002-10-23 | Antidiabetic 2-substituted-5′-O-(1-Boranotriphosphate) adenosine derivatives |
PCT/IL2002/000845 WO2003034978A2 (fr) | 2001-10-24 | 2002-10-23 | Derives antidiabetiques de 5'-o-(1-boranotriphosphate) adenosine-2-substituee |
ZA200402697A ZA200402697B (en) | 2001-10-24 | 2004-04-06 | Antidiabetic 2-substituted-5'-O-(1-boranotriphosphate) adenosine derivatives. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL14614201A IL146142A0 (en) | 2001-10-24 | 2001-10-24 | 2-substituted-5'-o-(1-boranotriphosphate adenosine derivatives and pharmaceutical compositions comprising them for treatment of type 2 diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
IL146142A0 true IL146142A0 (en) | 2002-07-25 |
Family
ID=11075840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14614201A IL146142A0 (en) | 2001-10-24 | 2001-10-24 | 2-substituted-5'-o-(1-boranotriphosphate adenosine derivatives and pharmaceutical compositions comprising them for treatment of type 2 diabetes |
Country Status (10)
Country | Link |
---|---|
US (1) | US7319093B2 (fr) |
EP (1) | EP1446132A4 (fr) |
JP (1) | JP2005508970A (fr) |
CN (1) | CN1575180A (fr) |
BR (1) | BR0206190A (fr) |
CA (1) | CA2462250A1 (fr) |
IL (1) | IL146142A0 (fr) |
NZ (1) | NZ532171A (fr) |
WO (1) | WO2003034978A2 (fr) |
ZA (1) | ZA200402697B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7368439B2 (en) * | 2005-06-15 | 2008-05-06 | Bar - Ilan University | Dinucleoside poly(borano)phosphate derivatives and uses thereof |
US20100256086A1 (en) * | 2007-11-23 | 2010-10-07 | Bar-Ilan Univetrsity | Non-hydrolyzable nucleoside di- or tri-phosphate derivatives and uses thereof |
EP2547343A4 (fr) * | 2010-03-19 | 2013-06-19 | Univ Miami | Utilisation d'agonistes de récepteur purinergique de type p2x pour renforcer la sécrétion d'insuline dans les cellules bêta pancréatique |
EP2426202A1 (fr) * | 2010-09-03 | 2012-03-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Kinases en tant que cibles pour thérapie antidiabétique |
US9458463B2 (en) * | 2010-09-03 | 2016-10-04 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for treatment of diabetes by a small molecule inhibitor for GRK5 |
CN103339136A (zh) * | 2010-12-01 | 2013-10-02 | 巴伊兰大学 | 尿苷二-或三-磷酸衍生物以及其用途 |
WO2013132489A1 (fr) * | 2012-03-05 | 2013-09-12 | Bar-Ilan University | Analogues de nucléoside 5'-phosphorothioate et leurs utilisations |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5143907A (en) * | 1991-05-10 | 1992-09-01 | Boron Biologicals, Inc. | Phosphite-borane compounds, and method of making and using the same |
US5434143A (en) * | 1991-05-10 | 1995-07-18 | Boron Biologicals, Inc. | Pharmaceutical compositions comprising phosphite-borane compounds |
US5260427A (en) * | 1991-05-10 | 1993-11-09 | Boron Biolgicals, Inc. | Nucleosidylphosphite-borane compounds and method of making the same |
US5547942A (en) * | 1994-01-04 | 1996-08-20 | Rapaport; Eliezer | Method of treatment of diabetes mellitus by administration of adenosine 5'-t |
US5986086A (en) * | 1997-06-20 | 1999-11-16 | Amersham Pharmacia Biotech Inc. | Non-sulfonated cyanine dyes for labeling nucleosides and nucleotides |
DE60122285D1 (de) | 2000-01-14 | 2006-09-28 | Us Gov Health & Human Serv | Methonocarbacycloalkylanaloga von nucleosiden |
US6900308B2 (en) | 2001-07-16 | 2005-05-31 | Isis Pharmaceuticals, Inc. | α-modified nucleoside triphosphates |
-
2001
- 2001-10-24 IL IL14614201A patent/IL146142A0/xx unknown
-
2002
- 2002-10-23 NZ NZ532171A patent/NZ532171A/en unknown
- 2002-10-23 CN CNA028211936A patent/CN1575180A/zh active Pending
- 2002-10-23 WO PCT/IL2002/000845 patent/WO2003034978A2/fr not_active Application Discontinuation
- 2002-10-23 JP JP2003537547A patent/JP2005508970A/ja active Pending
- 2002-10-23 EP EP02777766A patent/EP1446132A4/fr not_active Withdrawn
- 2002-10-23 BR BR0206190-2A patent/BR0206190A/pt not_active IP Right Cessation
- 2002-10-23 CA CA002462250A patent/CA2462250A1/fr not_active Abandoned
- 2002-10-23 US US10/493,461 patent/US7319093B2/en not_active Expired - Fee Related
-
2004
- 2004-04-06 ZA ZA200402697A patent/ZA200402697B/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20050065108A1 (en) | 2005-03-24 |
WO2003034978A3 (fr) | 2004-03-11 |
WO2003034978A2 (fr) | 2003-05-01 |
US7319093B2 (en) | 2008-01-15 |
ZA200402697B (en) | 2005-06-06 |
EP1446132A2 (fr) | 2004-08-18 |
BR0206190A (pt) | 2004-02-03 |
NZ532171A (en) | 2006-02-24 |
CN1575180A (zh) | 2005-02-02 |
JP2005508970A (ja) | 2005-04-07 |
EP1446132A4 (fr) | 2006-02-15 |
CA2462250A1 (fr) | 2003-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0400114A3 (en) | N-benzoyl-benzenesulfonamid derivatives as antitumor agents and pharmaceutical compositions containing them | |
IL192937A0 (en) | Pharmaceutical compositions containing beta-lapachone or derivatives or analogs thereof, and methods of using same | |
HUP0401567A3 (en) | Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them | |
IL147217A0 (en) | New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain | |
PL374781A1 (en) | 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections | |
HUP0300207A3 (en) | 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes | |
ZA200410290B (en) | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections | |
HUP0401160A3 (en) | 2,4,5-trisubstituted thiazolyl derivatives having antiinflammatory activity, process for their preparation and pharmaceutical compositions containing them | |
HUP0103406A3 (en) | 1h-imidazopyridine derivatives and pharmaceutical compositions thereof | |
HUP0400052A3 (en) | Carboxamide-substituted phenylurea derivatives and pharmaceutical compositions containing them and their use | |
HUP0200588A2 (hu) | Diarilszármazékok és azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0400246A3 (en) | 1,2,4-trioxolane antimalarial pharmaceutical compositions and process for their preparation and use | |
AU9018898A (en) | Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments | |
HUP0303998A3 (en) | Phthalazinones derivatives and pharmaceutical compositions containing them | |
HUP0101381A3 (en) | Benzofurylpyrone derivatives and pharmaceutical compositions containing them | |
HUP0401403A3 (en) | 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them | |
HUP0105204A3 (en) | Substituted phenethylamine derivatives and pharmaceutical compositions containing them | |
HUP0103203A3 (en) | Azaadamantane derivatives and pharmaceutical compositions thereof | |
IL158236A0 (en) | Pharmaceutical compositions containing azithromycin and derivatives thereof | |
PL352293A1 (en) | Derivatives of purine, method of making same and pharmaceutical compositions containing these derivatives | |
HUP0105481A3 (en) | Pharmaceutical compositions containing clarithromycin and process for their preparation and their use | |
HUP0102025A3 (en) | Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use | |
HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them | |
HUP0401325A3 (en) | Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds | |
IL146142A0 (en) | 2-substituted-5'-o-(1-boranotriphosphate adenosine derivatives and pharmaceutical compositions comprising them for treatment of type 2 diabetes |